Journal article
Combination chemotherapy with bleomycin, etoposide, and cisplatin in metastatic non-small-cell lung cancer.
Abstract
Fifty-three patients with recurrent and advanced stage (III and IV) non-small-cell lung cancer (NSCLC) were treated with a combination of bleomycin, etoposide (VP-16-213), and cis-diamminedichloroplatinum (BEP). Forty-eight patients were appraisable for response. The response rates were 44% for the entire group, 57% in 30 patients with combined squamous-cell and large-cell carcinoma, and 22% in 18 patients with adenocarcinoma (40%, 50%, and …
Authors
Osoba D; Rusthoven JJ; Turnbull KA; Evans WK; Shepherd FA
Journal
Journal of Clinical Oncology, Vol. 3, No. 11, pp. 1478–1485
Publisher
American Society of Clinical Oncology (ASCO)
Publication Date
November 1985
DOI
10.1200/jco.1985.3.11.1478
ISSN
0732-183X